QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 salarius-pharmaceuticals-amends-merger-terms-with-decoy-to-set-1050-baseline-conversion-price-375-floor-price-for-preferred-stock

As previously disclosed, Salarius Pharmaceuticals, Inc. (the "Company") entered into an Agreement and Plan of Merger da...

 reported-earlier-salarius-pharmaceuticals-granted-nasdaq-extension-to-regain-compliance-with-equity-and-minimum-bid-price-requirements-by-august-2025

On July 28, 2025, Salarius Pharmaceuticals, Inc. ("Salarius") received notification from The Nasdaq Stock Market LLC (&...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION